These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20950862)

  • 1. Rate of non-adherence prior to upward dose titration in previously stable antidepressant users.
    Muzina DJ; Malone DA; Bhandari I; Lulic R; Baudisch R; Keene M
    J Affect Disord; 2011 Apr; 130(1-2):46-52. PubMed ID: 20950862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Duration of antidepressant drug treatment and its determinants in France].
    Tournier M; Cougnard A; Boutouaba-Combe S; Verdoux H
    Encephale; 2011 May; 37 Suppl 1():S36-41. PubMed ID: 21600331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders.
    Lee MS; Lee HY; Kang SG; Yang J; Ahn H; Rhee M; Ko YH; Joe SH; Jung IK; Kim SH
    J Affect Disord; 2010 Jun; 123(1-3):216-21. PubMed ID: 19914719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistency of antidepressant and chronic nonpsychiatric medication use in a high-risk clinical population.
    Carnahan RM; Lund BC; Chrischilles EA; Perry PJ
    Res Social Adm Pharm; 2008 Dec; 4(4):367-74. PubMed ID: 19064243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of antidepressant adherence: results of a Japanese Internet-based survey.
    Shigemura J; Ogawa T; Yoshino A; Sato Y; Nomura S
    Psychiatry Clin Neurosci; 2010 Apr; 64(2):179-86. PubMed ID: 20132528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of antidepressant treatment for depressive disorder in Taiwan.
    Wu CS; Shau WY; Chan HY; Lai MS
    Gen Hosp Psychiatry; 2013; 35(3):279-85. PubMed ID: 23415578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' perceptions and illness severity at start of antidepressant treatment in general practice.
    van Geffen EC; Heerdink ER; Hugtenburg JG; Siero FW; Egberts AC; van Hulten R
    Int J Pharm Pract; 2010 Aug; 18(4):217-25. PubMed ID: 20636673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
    Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
    J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Just keep taking the tablets: adherence to antidepressant treatment in older people in primary care.
    Maidment R; Livingston G; Katona C
    Int J Geriatr Psychiatry; 2002 Aug; 17(8):752-7. PubMed ID: 12211126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between patient-reported drug taking and gaps and overlaps in antidepressant drug dispensing.
    Gardarsdottir H; Egberts TC; Heerdink ER
    Ann Pharmacother; 2010 Nov; 44(11):1755-61. PubMed ID: 20940343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to continuation and maintenance antidepressant use in recurrent depression.
    ten Doesschate MC; Bockting CL; Schene AH
    J Affect Disord; 2009 May; 115(1-2):167-70. PubMed ID: 18760488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of antidepressant drug treatment and its influence on risk of relapse/recurrence: immortal and neglected time bias.
    Gardarsdottir H; Egberts TC; Stolker JJ; Heerdink ER
    Am J Epidemiol; 2009 Aug; 170(3):280-5. PubMed ID: 19498074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antilipidemic adherence post-coronary artery disease diagnosis among those with and without an ICD-9 diagnosis of depression.
    May HT; Sheng X; Catinella AP; Horne BD; Carlquist JF; Joy E
    J Psychosom Res; 2010 Aug; 69(2):169-74. PubMed ID: 20624515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Switch antidepressants: when? How? Why?].
    Gourion D; Galinowski A; Baraille L; Picard H
    Encephale; 2011 May; 37 Suppl 1():S50-7. PubMed ID: 21600334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication adherence and its effect on relapse among patients discharged from a Veterans Affairs posttraumatic stress disorder treatment program.
    Lockwood A; Steinke DT; Botts SR
    Ann Pharmacother; 2009 Jul; 43(7):1227-32. PubMed ID: 19584387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Working with reactant patients: are we prescribing nonadherence?
    Madsen JW; McQuaid JR; Craighead WE
    Depress Anxiety; 2009; 26(2):129-34. PubMed ID: 18972363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label, dose-finding study of WY-45,030, a novel bicyclic antidepressant.
    Schweizer E; Clary C; Weise C; Rickels K
    Psychopharmacol Bull; 1988; 24(1):195-7. PubMed ID: 3387522
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of an antidepressant management program on medication adherence.
    Hoffman L; Enders J; Luo J; Segal R; Pippins J; Kimberlin C
    Am J Manag Care; 2003 Jan; 9(1):70-80. PubMed ID: 12549816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of antidepressant medication adherence with employee disability absences.
    Burton WN; Chen CY; Conti DJ; Schultz AB; Edington DW
    Am J Manag Care; 2007 Feb; 13(2):105-12. PubMed ID: 17286530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.